← Leaderboards
Deborah Lynne Jones
Barry University
$19,202,871
Attributed
$45,066,285
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.6M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,066,285 · 16
By mechanism
U01$18,080,014 · 1
R01$15,362,133 · 6
OT2$7,470,021 · 1
R24$1,373,139 · 1
R21$731,123 · 2
R34$607,796 · 1
Top collaborators
- Maria Luisa Alcaide23 shared
- Margaret A Fischl14 shared
- Karl F Peltzer6 shared
- Mahendra Kumar5 shared
- Olveen Carrasquillo4 shared
- Daniel J Feaster4 shared
- Carrigan L Parish4 shared
- Mattia Prosperi4 shared
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantBehavioralWomanCohortSiteBaseHiv InfectionsProgramsEnrollmentEpidemicCountryPublic HealthCaringFloridaIncidenceComorbidityResearch PersonnelSocial StigmaInnovationLeadCommunitiesFollow-UpTransmission ProcessAntiretroviral Therapy
Grant awards (66)
MACS/WIHS -CCS$2,590,415
U01 · FY2025 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$725,727
R01 · FY2025 · AI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$635,546
R01 · FY2025 · DE · contact PI
Good Living for Women: GLOW$395,837
U19 · FY2025 · HD · contact PI
SOURI (SMILE)$213,135
R01 · FY2025 · DE · contact PI
Cardiovascular Research Empowerment Workforce$166,303
R25 · FY2025 · HL
MACS/WIHS -CCS$2,554,017
U01 · FY2024 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$738,604
R01 · FY2024 · AI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$614,764
R01 · FY2024 · DE · contact PI
Cardiovascular Research Empowerment Workforce$166,303
R25 · FY2024 · HL
SouthEast Enrollment Center (SEEC)$7,470,021
OT2 · FY2023 · OD
MACS/WIHS -CCS$2,569,967
U01 · FY2023 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$744,241
R01 · FY2023 · AI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$635,251
R01 · FY2023 · DE · contact PI
Cardiovascular Research Empowerment Workforce$166,303
R25 · FY2023 · HL
MACS/WIHS -CCS$2,629,147
U01 · FY2022 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$776,744
R01 · FY2022 · AI
MACS/WIHS -CCS-Supplement$14,148
U01 · FY2022 · HL
MACS/WIHS -CCS$2,599,372
U01 · FY2021 · HL
Innovation Fund Application to the Multicenter AIDS Cohort Study (MACS)/Womens Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB)$33,764
U01 · FY2021 · HL
MACS/WIHS -CCS$2,485,217
U01 · FY2020 · HL
Research Core-MHD$233,399
P30 · FY2020 · MH · contact PI
MACS/WIHS -CCS$50,218
U01 · FY2020 · HL
MACS/WIHS -CCS$25,171
U01 · FY2020 · HL
MACS/WIHS -CCS$20,095
U01 · FY2020 · HL
MACS/WIHS -CCS$17,732
U01 · FY2020 · HL
MACS/WIHS -CCS$2,000,000
U01 · FY2019 · HL
Positive Connections: COPA2$503,923
R01 · FY2019 · MH · contact PI
MACS/WIHS -CCS$469,240
U01 · FY2019 · HL
Research Core-MHD$233,399
P30 · FY2019 · MH · contact PI
MACS/WIHS -CCS$21,511
U01 · FY2019 · HL
Positive Connections: COPA2$508,800
R01 · FY2018 · MH · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$464,823
R01 · FY2018 · DA
Positive Connections: COPA2$539,790
R01 · FY2017 · MH · contact PI
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$507,251
R01 · FY2017 · HD · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$478,258
R01 · FY2017 · DA
Positive Connections: COPA2$151,849
R01 · FY2017 · MH · contact PI
Positive Connections: COPA2$645,369
R01 · FY2016 · MH · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$614,529
R01 · FY2016 · DA
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$491,982
R01 · FY2016 · HD · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$621,873
R01 · FY2015 · DA
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$483,631
R01 · FY2015 · HD · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$645,968
R01 · FY2014 · DA
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$482,145
R01 · FY2014 · HD · contact PI
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$321,861
R01 · FY2014 · HD · contact PI
Positive Connections$160,453
R34 · FY2014 · MH · contact PI
Implementing Comprehensive PMTCT and HIV Prevention for South African Couples$521,553
R01 · FY2013 · HD · contact PI
Positive Connections$186,748
R34 · FY2013 · MH · contact PI
Implementing HIV Risk Reduction Zambia$365,000
R01 · FY2012 · HD · contact PI
Positive Connections$260,595
R34 · FY2012 · MH · contact PI
Implementing HIV Risk Reduction Zambia$421,402
R01 · FY2011 · HD · contact PI
Implementing HIV Risk Reduction Zambia$515,698
R01 · FY2010 · HD · contact PI
Enhancing HIV Medication Adherence in India$160,298
R21 · FY2010 · NR · contact PI
Longitudinal Dyadic Analysis of HIV-positive Substance Users with Trauma History$80,515
K18 · FY2010 · DA · contact PI
Implementing HIV Risk Reduction Zambia$464,000
R01 · FY2009 · HD · contact PI
Enhancing HIV Medication Adherence in India$213,879
R21 · FY2009 · NR · contact PI
Implementing HIV Risk Reduction Zambia$102,796
R01 · FY2009 · HD · contact PI
Implementing HIV Risk Reduction Zambia$425,620
R01 · FY2008 · HD · contact PI
Interventions to Enhance HIV Medication Adherence in Zambia$177,501
R21 · FY2007 · AI · contact PI
Zambia/US Research Partnership in HIV Prevention$181,800
R24 · FY2006 · HD · contact PI
Interventions to Enhance HIV Medication Adherence in Zambia$179,445
R21 · FY2006 · AI · contact PI
Zambia/US Research Partnership in HIV Prevention$57,049
R24 · FY2006 · HD · contact PI
Zambia/US Research Partnership in HIV Prevention$258,654
R24 · FY2005 · HD
Zambia/US Research Partnership in HIV Prevention$313,836
R24 · FY2004 · HD
Zambia/US Research Partnership in HIV Prevention$281,890
R24 · FY2003 · HD
Zambia/US Research Partnership in HIV Prevention$279,910
R24 · FY2002 · HD